Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.,Analytical Chemistry - X-MOL
How Far We Have Advanced in the Chemotherapy World - IBL America Online Store
Pharmaceuticals | Free Full-Text | Antibody–Drug Conjugates: The Last Decade | HTML
Conjugation methods for ADC development. ADC production using... | Download Scientific Diagram
Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation - ScienceDirect
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
BTG-driven conjugation: Antibodies for medicine
PDF) Antibody–Drug Conjugates: Perspectives and Characterization
PDF) Site-Specific Antibody Conjugation for ADC and Beyond
PDF) Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)
Cleavable linkers in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C8CS00676H
Antibody–drug conjugates | Nature Reviews Drug Discovery
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin | Scientific Reports
Antibody–Drug Conjugates: Perspectives and Characterization | Chromatography Online
On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency | Scientific Reports
Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology
Frontiers | The Analysis of Key Factors Related to ADCs Structural Design | Pharmacology
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin
PDF) Analytical methods for physicochemical characterization of antibody drug conjugates
Anti-Cancer ADC Drugs: 3 Design Elements, 10 Approved ADCs, Multiple Clinical Trials | Biochempeg
Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery
Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody–Drug Conjugates | SpringerLink
Antibody-drug conjugate - Wikipedia
